These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 39407614)

  • 1. Breath Analysis: Identification of Potential Volatile Biomarkers for Non-Invasive Diagnosis of Chronic Kidney Disease (CKD).
    Di Gilio A; Palmisani J; Nisi M; Pizzillo V; Fiorentino M; Rotella S; Mastrofilippo N; Gesualdo L; de Gennaro G
    Molecules; 2024 Oct; 29(19):. PubMed ID: 39407614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of potential chronic kidney disease markers in breath using gas chromatography with mass-spectral detection coupled with thermal desorption method.
    Grabowska-Polanowska B; Faber J; Skowron M; Miarka P; Pietrzycka A; Sliwka I; Amann A
    J Chromatogr A; 2013 Aug; 1301():179-89. PubMed ID: 23764192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled volatile substances mirror clinical conditions in pediatric chronic kidney disease.
    Obermeier J; Trefz P; Happ J; Schubert JK; Staude H; Fischer DC; Miekisch W
    PLoS One; 2017; 12(6):e0178745. PubMed ID: 28570715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploration of Potential Breath Biomarkers of Chronic Kidney Disease through Thermal Desorption-Gas Chromatography/Mass Spectrometry.
    Seong SH; Kim HS; Lee YM; Kim JS; Park S; Oh J
    Metabolites; 2023 Jul; 13(7):. PubMed ID: 37512544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a characteristic VOCs pattern in the exhaled breath of post-COVID subjects: are metabolic alterations induced by the infection still detectable?
    Di Gilio A; Palmisani J; Picciariello A; Zambonin C; Aresta A; De Vietro N; Franchini SA; Ventrella G; Nisi MR; Licen S; Barbieri P; Altomare DF; de Gennaro G
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37379826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of exhaled volatile organic compounds that characterize asthma phenotypes: A J-VOCSA study.
    Suzukawa M; Ohta K; Sugimoto M; Ohshima N; Kobayashi N; Tashimo H; Tanimoto Y; Itano J; Kimura G; Takata S; Nakano T; Yamashita T; Ikegame S; Hyodo K; Abe M; Chibana K; Kamide Y; Sasaki K; Hashimoto H
    Allergol Int; 2024 Oct; 73(4):524-531. PubMed ID: 38658257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The application of chromatographic breath analysis in the search of volatile biomarkers of chronic kidney disease and coexisting type 2 diabetes mellitus.
    Grabowska-Polanowska B; Skowron M; Miarka P; Pietrzycka A; Śliwka I
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():103-110. PubMed ID: 28605624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exhaled breath and fecal volatile organic biomarkers of chronic kidney disease.
    Meinardi S; Jin KB; Barletta B; Blake DR; Vaziri ND
    Biochim Biophys Acta; 2013 Mar; 1830(3):2531-7. PubMed ID: 23274524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breath volatile organic compounds of lung transplant recipients with and without chronic lung allograft dysfunction.
    Küppers L; Holz O; Schuchardt S; Gottlieb J; Fuge J; Greer M; Hohlfeld JM
    J Breath Res; 2018 Jun; 12(3):036023. PubMed ID: 29771243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volatile organic compounds in exhaled breath are independent of systemic inflammatory syndrome caused by intravenous lipopolysaccharide infusion in humans: results from an experiment in healthy volunteers.
    Peters AL; Gerritsen MG; Brinkman P; Zwinderman KAH; Vlaar APJ; Bos LD
    J Breath Res; 2017 Apr; 11(2):026003. PubMed ID: 28397711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual center study to compare breath volatile organic compounds from smokers and non-smokers with and without COPD.
    Gaida A; Holz O; Nell C; Schuchardt S; Lavae-Mokhtari B; Kruse L; Boas U; Langejuergen J; Allers M; Zimmermann S; Vogelmeier C; Koczulla AR; Hohlfeld JM
    J Breath Res; 2016 Apr; 10(2):026006. PubMed ID: 27082437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between cancer tissue derived and exhaled volatile organic compound from colorectal cancer patients. Preliminary results.
    De Vietro N; Aresta A; Rotelli MT; Zambonin C; Lippolis C; Picciariello A; Altomare DF
    J Pharm Biomed Anal; 2020 Feb; 180():113055. PubMed ID: 31877489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breath volatile organic compounds for chronic kidney disease progression monitoring.
    Li L; Wang J; Feng F; Yan J; Zhao B; Li X; Zhong Y
    Analyst; 2024 Feb; 149(4):1074-1080. PubMed ID: 37955046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease.
    Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R
    J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
    Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
    Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive detection of renal disease biomarkers through breath analysis.
    Khokhar M
    J Breath Res; 2024 Jan; 18(2):. PubMed ID: 38099568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-induced Volatile Organic Compounds Are Detectable in Exhaled Breath during Pulmonary Infection.
    Kamal F; Kumar S; Edwards MR; Veselkov K; Belluomo I; Kebadze T; Romano A; Trujillo-Torralbo MB; Shahridan Faiez T; Walton R; Ritchie AI; Wiseman DJ; Laponogov I; Donaldson G; Wedzicha JA; Johnston SL; Singanayagam A; Hanna GB
    Am J Respir Crit Care Med; 2021 Nov; 204(9):1075-1085. PubMed ID: 34319857
    [No Abstract]   [Full Text] [Related]  

  • 18. VOC biomarkers identification and predictive model construction for lung cancer based on exhaled breath analysis: research protocol for an exploratory study.
    Li W; Dai W; Liu M; Long Y; Wang C; Xie S; Liu Y; Zhang Y; Shi Q; Peng X; Liu Y; Li Q; Duan Y
    BMJ Open; 2019 Aug; 9(8):e028448. PubMed ID: 31399453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory study on noninvasive biomarker of silicosis in exhaled breath by solid-phase microextraction-gas chromatography-mass spectrometry analysis.
    Yi Z; Dong S; Wang X; Xu M; Li Y; Xie L
    Int Arch Occup Environ Health; 2023 Aug; 96(6):857-868. PubMed ID: 37067574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breath Analysis: Comparison among Methodological Approaches for Breath Sampling.
    Di Gilio A; Palmisani J; Ventrella G; Facchini L; Catino A; Varesano N; Pizzutilo P; Galetta D; Borelli M; Barbieri P; Licen S; de Gennaro G
    Molecules; 2020 Dec; 25(24):. PubMed ID: 33321824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.